“…In fact, a few studies reported the role of BAE exclusively in patients with active TB and/or post-TB sequelae (9,18,21,25,27). On the other hand, malignancies, nontubercular mycobacterial infections, lung abscesses, vasculitis, and cryptogenic hemoptysis were Bronchial artery embolization in hemoptysis • 309 more common in studies published from Western population (8,12). In the study by Tom et al (12), which reported BAE experience in 69 patients from the United States, sarcoidosis and cystic fibrosis were the most common indications, comprising 36% of patient population while TB and post-TB sequelae formed only 8% of the patient population.…”